TrialBlood2008

High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.

Christian Langer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.